In this study, we used HLJ1-knockout (Dnajb4–/–) mice and demonstrated that HLJ1 deficiency leads to hepatic gene signatures linked to chemical-induced liver cancer and IL-6/STAT3 signaling. Here, STAT3 is linked to liver cancer.